Search

everythinglearnresearchcommunity

for

Search:↓

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

A woman had a rare reaction to ear piercing that caused earlobe swelling, which was best treated by removing the piercing and not re-piercing.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Oral tofacitinib successfully treated total body hair loss in one patient.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Hair follicles prevent NK cell attacks to avoid hair loss.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Topical sensitizers have mixed success in treating alopecia areata.

Netherton's syndrome is linked to high IgE levels and unique skin and hair symptoms, and may improve with ammonium lactate lotion and allergy management.

Skin aging is a complex process influenced by various factors, leading to wrinkles and sagging, and should be considered a disease due to its health impacts.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Targeting TGFβ can improve skin immunity in older people.